期刊文献+

桥本氏脑病的MRI表现与临床对比

MRI manifestations and clinical analysis of Hashimoto encephalopathy
原文传递
导出
摘要 目的分析和研究桥本氏脑病患者的临床表现、诊断标准,MRI表现及预后。方法选取2009年以来病例12例,均检测抗甲状腺抗体、特别是抗甲状腺过氧化物酶抗体,并行脑电图检查,治疗前均行MRI、MRA检查,激素治疗6个月-2年,治疗后复查MRI、MRA。结果本组患者均表现为卒中样发作、精神症状、癫痫样发作等症状,检查抗甲状腺抗体增高,特别是抗甲状腺过氧化物酶抗体明显增高,脑电图脑内广泛异常慢波,MRI见脑内多发异常信号,MRA见脑内动脉多发狭窄,激素治疗6个月-2年,患者症状恢复,复查MRI、MRA,脑内异常信号大部分消失,MRA血管狭窄明显改善。结论桥本氏脑病MRI脑内多发异常信号,MRA脑血管多发狭窄,正确认识本病,可减少漏诊和误诊。 Objective To analyze and research clinical manifestations,diagnostic criteria,MRI manifestations and prognosis of Hashimoto's encephalopathy. Methods Cases since 2009,12 cases were selected,all testing anti- thyroid antibodies,especially the resistance to thyroid peroxidase antibody,parallel eeg examination,MRI,MRA examination were performed before treatment,hormone treatment for 6 months to 2 years,MRI and MRA review after treatment. Results This group of patients were characterized by sample seizures,mental symptoms of stroke,epileptic seizures and other symptoms,check anti- thyroid antibodies increased,especially the thyroid peroxidase antibody significantly higher resistance,abnormal eeg in the brain are widely slow wave,see multiple abnormal signals in the brain MRI,MRA see frequent brain artery stenosis,hormone treatment for 6 months to 2 years,patients with symptoms,MRI,MRA,review the brain most abnormal signal disappears,MRA vascular stenosis improved significantly. Conclusion Hashimoto encephalopathy multiple abnormal signals in MRI brain,MRA frequent cerebrovascular stenosis,understanding of the disease,can reduce missed diagnosis and misdiagnosis.
作者 贾爱英
出处 《医药论坛杂志》 2014年第9期48-49,共2页 Journal of Medical Forum
关键词 桥本氏脑病 抗甲状腺抗体 MRI、MRA异常 Hashimoto's encephalopathy Anti-thyroid antibody MRI MRA Abnormal
  • 相关文献

参考文献6

二级参考文献34

  • 1章秋 杨明功.内分泌疾病的神经系统表现[A].韩仲岩主编.全身疾病的神经系统表现[C].北京:人民军医出版社,2001.384-385.
  • 2何伋 何笈 马恩轩 成义仁主编.甲状腺机能亢进症[A].何笈,马恩轩,成义仁主编.内科疾病精神症状与精神障碍[C].济南:山东科学技术出版社,1994.220-222.
  • 3Chaudhuri A, Behan PO. The clinical spectrum, diagnosis, pathogenesis and treatment of Hashimoto's encephalopathy( recurrent acute disseminated encephalomyelitis)[J]. Curr Med- Chem, 2003, 10(19): 1945- 1953.
  • 4Fatourechi V. Hashimoto' s encephalopathy: myth or reality? An endocrinologist's perspective[J]. Best Pract Res Clin EndocrinolMetab, 2005, 19(1) : 53-66.
  • 5Tamagno G. Clinical and diagnostic aspects of encephalopath- yassociated with autoimmune thyroid disease ( or Hashimoto' sencephalopathy)[J]. Intern Emerg Med, 2006, 1 (1) : 15-23.
  • 6Ochi H, Horiuchi I, Araki N, et al. Proteomic analysis of human brain identifies alpha-enolase as a novel autoantigen inHashimoto' s encephalopathy[J].FEBS Lett, 2002, 528 (1/ 3) : 197-201.
  • 7Ferlazzo E, RaffaeleM, Mazzu I, et al. Recurrent status ep-ilepticus as the main feature ofHashimoto's encephalopathy[J]. Epilepsy Behav, 2006, 8(1): 328-330.
  • 8Ferracci F, Bertiato G, Moretto G. Hashimoto's encephalopathy: epidemiologic data and pathogenetic considerations[J]. J Neurol Sci, 2004, 217(2): 165-168.
  • 9Brain L, Jellinek EH, Ball K. Hashimoto's disease and encephalopathy. Lancet, 1966,2 (7462) : 512-514.
  • 10Moeellin R, Walterfang M, Velakoulis D. Hashimoto's encephalopathy: epidemiology, pathogenesis and management. CNS Drugs, 2007,21 (10) : 799-811.

共引文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部